<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1AD40E62-7557-4E8B-9C5A-A0B7214CD890"><gtr:id>1AD40E62-7557-4E8B-9C5A-A0B7214CD890</gtr:id><gtr:name>Iowa State University</gtr:name><gtr:address><gtr:line3>IA 50011</gtr:line3><gtr:line4>Ames</gtr:line4><gtr:line5>Iowa</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E9486EB9-D3D0-42B0-B16C-03D624CE3B22"><gtr:id>E9486EB9-D3D0-42B0-B16C-03D624CE3B22</gtr:id><gtr:name>Genus plc</gtr:name><gtr:address><gtr:line1>Belvedere House</gtr:line1><gtr:line2>Basing View</gtr:line2><gtr:line4>Basingstoke</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>RG21 4HG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23BEE04F-45E4-4945-B5E3-7D21352F272F"><gtr:id>23BEE04F-45E4-4945-B5E3-7D21352F272F</gtr:id><gtr:name>Zoetis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0E80DBC1-A928-4E7B-8553-F59869930C27"><gtr:id>0E80DBC1-A928-4E7B-8553-F59869930C27</gtr:id><gtr:name>Virginia Polytechnic Institute &amp; State U</gtr:name><gtr:address><gtr:line1>Virginia Polytechnic Inst &amp; State  Univ</gtr:line1><gtr:line4>Blacksburg</gtr:line4><gtr:line5>Virginia</gtr:line5><gtr:postCode>VA 24061</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1AD40E62-7557-4E8B-9C5A-A0B7214CD890"><gtr:id>1AD40E62-7557-4E8B-9C5A-A0B7214CD890</gtr:id><gtr:name>Iowa State University</gtr:name><gtr:address><gtr:line3>IA 50011</gtr:line3><gtr:line4>Ames</gtr:line4><gtr:line5>Iowa</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E9486EB9-D3D0-42B0-B16C-03D624CE3B22"><gtr:id>E9486EB9-D3D0-42B0-B16C-03D624CE3B22</gtr:id><gtr:name>Genus plc</gtr:name><gtr:address><gtr:line1>Belvedere House</gtr:line1><gtr:line2>Basing View</gtr:line2><gtr:line4>Basingstoke</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>RG21 4HG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23BEE04F-45E4-4945-B5E3-7D21352F272F"><gtr:id>23BEE04F-45E4-4945-B5E3-7D21352F272F</gtr:id><gtr:name>Zoetis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9B520E8D-05F2-4A18-9EDF-C1503366E9E1"><gtr:id>9B520E8D-05F2-4A18-9EDF-C1503366E9E1</gtr:id><gtr:name>Eli Lilly &amp; Company Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0E80DBC1-A928-4E7B-8553-F59869930C27"><gtr:id>0E80DBC1-A928-4E7B-8553-F59869930C27</gtr:id><gtr:name>Virginia Polytechnic Institute &amp; State U</gtr:name><gtr:address><gtr:line1>Virginia Polytechnic Inst &amp; State  Univ</gtr:line1><gtr:line4>Blacksburg</gtr:line4><gtr:line5>Virginia</gtr:line5><gtr:postCode>VA 24061</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E913F6AA-9FFC-4300-83DB-799EC8F3A4E7"><gtr:id>E913F6AA-9FFC-4300-83DB-799EC8F3A4E7</gtr:id><gtr:name>University of Maryland</gtr:name><gtr:address><gtr:line1>University of Maryland</gtr:line1><gtr:postCode>20742</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BE941673-99F3-43CA-A4BB-66DA04A4915C"><gtr:id>BE941673-99F3-43CA-A4BB-66DA04A4915C</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Digard</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FD%2F20241866"><gtr:id>1D558272-7E44-4A4E-ACB6-9F78A213AE7E</gtr:id><gtr:title>Novel strategies to control virus infection and disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/D/20241866</gtr:grantReference><gtr:abstractText>Endemic and exotic virus diseases are threats to food security and, in some cases, potential zoonoses. We aim to develop novel strategies to control virus infection, focussing on improving animal welfare and reducing the disease burden in food production animals. The objectives include i) development of vaccines based around pox virus and herpesvirus delivery systems; ii) exploitation of transgenesis as a means of delivering resistance genes including antiviral peptides. Preliminary studies suggest that it is possible to prevent or reduce virus transmission, infection or disease by genetic modification of mammalian/avian hosts; iii) development of the concept of a bioshield involving constitutive expression of antiviral peptides expressed by probiotic bacteria colonisation of the GI tract.</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>1042337</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eli Lilly &amp; Company Ltd</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Elanco</gtr:department><gtr:description>ELANCO collaboration</gtr:description><gtr:id>541E3E64-6C25-4D73-872E-8C172D7A3DB4</gtr:id><gtr:impact>Confidential</gtr:impact><gtr:outcomeId>58c7a10d663422.05260521-1</gtr:outcomeId><gtr:partnerContribution>Confidential</gtr:partnerContribution><gtr:piContribution>Confidential</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genus plc</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Roslin-Genus Cooperative Partnership Addendum 16</gtr:description><gtr:id>7D5693A0-29AA-4A85-A235-129BC3C416B6</gtr:id><gtr:impact>Paper published: Burkard et al. 2017. PLOS Pathogens 1392): e1006206</gtr:impact><gtr:outcomeId>58c80e9544dc12.96525065-1</gtr:outcomeId><gtr:partnerContribution>The Genus team contributed to the project design and management.</gtr:partnerContribution><gtr:piContribution>The Roslin Institute team conceived and executed the research project to test the hypothesis that gene-editing the pig CD163 gene would confer resistance to infection with PRRSV.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Zoetis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Zoetis collaboration</gtr:description><gtr:id>FBE44FC2-5176-4420-BBAA-C4CF58EF101E</gtr:id><gtr:impact>None at this point.</gtr:impact><gtr:outcomeId>58c7a0c0c7aff1.87439011-1</gtr:outcomeId><gtr:partnerContribution>Vaccine preparation</gtr:partnerContribution><gtr:piContribution>Development of the research idea, animal model and pathogen isolation</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Maryland, College Park</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>UM collaboration</gtr:description><gtr:id>4DB52764-B3B7-4AC0-A8EF-DD8E3C7166DE</gtr:id><gtr:impact>Several publications</gtr:impact><gtr:outcomeId>58c79f09b6e193.56997797-1</gtr:outcomeId><gtr:partnerContribution>Preparing virus and vaccine virus stocks</gtr:partnerContribution><gtr:piContribution>Performing vaccine efficacy studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Iowa State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>ISU collaboration</gtr:description><gtr:id>ADA89E9C-7237-4CA6-94EB-3C97A3A2F57B</gtr:id><gtr:impact>Several publications</gtr:impact><gtr:outcomeId>58c79e7c9888d0.85288058-1</gtr:outcomeId><gtr:partnerContribution>Providing laboratory and animal space</gtr:partnerContribution><gtr:piContribution>Providing knowhow and imput</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Virginia Tech</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>VT collaboration</gtr:description><gtr:id>620FD9F5-A339-40A3-87E9-DB05BDA44272</gtr:id><gtr:impact>Several publications</gtr:impact><gtr:outcomeId>58c79dc7b68321.18460411-1</gtr:outcomeId><gtr:partnerContribution>Developing vaccines</gtr:partnerContribution><gtr:piContribution>Developing of a pig model and testing viruses.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Edinburgh Science Festival, Flu Fighters</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AE8FAE5F-0F7D-46AB-8E62-BCE6FDC6BBD6</gtr:id><gtr:impact>Participated in Flu Fighters during the Edinburgh Science Festival 2015.
We showcased the exhibit 'Flu Fighters' at the festival. The 'Flu Fighters' exhibit focuses on influenza viruses and the science behind the varied approaches to combating flu being developed at Roslin and Pirbright. It showcases current research including GM animals, novel approaches to vaccines and diagnostic tests and host/virus genetics.
The exhibit also demonstrates how flu transmits from animals to humans and highlight the challenges of preventing large-scale outbreaks.The 'Flu Fighters' exhibit provides an opportunity for visitors to run diagnostic tests on a chicken, design their own flu virus and discuss the pros and cons of genetic modification of animals.
Over 100 people attended the morning and the activities sparked questions from both children and parents/carers. A better understanding of the problem for the poultry industry, eco system (wild birds) and human health was reported back.</gtr:impact><gtr:outcomeId>56d58bbf576e50.79352496</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Flu Fighters public exhibition stand</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A89951F7-DA6B-4611-AAD1-3E8BEA507688</gtr:id><gtr:impact>4. With &amp;pound;10k BBSRC funding, ISPG4-funded researchers jointly developed 'Flu-Fighters', an interactive exhibit suitable for children and adults highlighting our research to create influenza-resistant farm animals, develop improved vaccines and diagnostic tests, and understand the role of viral and host factors in the outcome of infection. This was run over three days in November 2014 at the Great British Bioscience Festival (visited by over 6500 people) as part of BBSRC's 20th anniversary programme. ISPG4 scientists were involved in running it again at the Royal Society's 2015 Summer Science Exhibition in London.</gtr:impact><gtr:outcomeId>56e03887eb36d2.50751634</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Come Dine With The Future</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4756F397-3BEE-4F88-A13A-A695A7C81CE3</gtr:id><gtr:impact>What will we be eating in 50 years time? H Sang and 4 other presenters described what will be on their dinner menu, considering advances in technology and challenges of sustainability</gtr:impact><gtr:outcomeId>58b3f66f502314.60022540</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=Bkta-s7z9DY</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Career event at Earlston High</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>55D31DA4-92CB-44AB-9A3C-94F206063C58</gtr:id><gtr:impact>Participated in school careers event at Earlston Highschool for pupils of S1. 
Participated as STEM ambassador, multiple talks on career as scientist including activity People like me set up by STEM.</gtr:impact><gtr:outcomeId>58b7fb9ca80ad9.42216468</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genome Editing and the Future of Farming</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7B09FA64-3DD4-4ADE-8469-8007F73BE487</gtr:id><gtr:impact>On the 6th September The Roslin Institute opened its doors to an array of delegates from the worlds of research, industry and policy to discuss genome editing and its role in the future of farming, with many international colleagues including from USDA and OECD.
The global challenge of food security is time critical as we will need to produce 70% more food by 2050 without destroying the environment. Innovations in food production techniques are urgently required. Editing the genomes of crops and livestock offers new possibilities to address this complex issue. The meeting discussed the status of the technologies in crops and farmed animals and the associated regualtory and societal challenges were debated, lead by presenters with a broad array of relevant expertise. My role was as chair of a session.</gtr:impact><gtr:outcomeId>58b5bcb42abf75.52629730</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.nib.ac.uk/reporting-on-the-first-nib-specialist-meeting-genome-editing-and-the-future-of-farming/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cabaret of Dangerous Ideas: Dolly the Sheep: major discovery or minor distraction? Presenter, Edinburgh Festival Fringe.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>78064A22-7866-422B-9A6D-B5CF8308A6C5</gtr:id><gtr:impact>Presentation with two colleagues, one a stem cell biologist and one a histrian of science in society, discussing the impact on research and society of the birth of Dolly the Sheep 20 years ago. Potential of GM technologies to confer resistance to diseases in farmed animals was discussed. Plenty of opportunity for audience contributions to debate.</gtr:impact><gtr:outcomeId>58b5bf2667c752.48343364</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.youtube.com/watch?v=LClmL5C9YJE&amp;feature=youtu.be</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>94126</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Animal Health Research Club</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M502984/1</gtr:fundingRef><gtr:id>94A367BB-EF13-4D15-A2F0-DC20D151D27B</gtr:id><gtr:outcomeId>58b5bd87d3c046.48953500</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Horizon 2020</gtr:department><gtr:description>EU H2020</gtr:description><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>E5E86D25-26FA-4FDB-BF7F-EE7B137A5111</gtr:id><gtr:outcomeId>58c11023d75e37.07214937</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CASE studentship</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/L004666/1</gtr:fundingRef><gtr:id>86CAE3D8-3094-4379-B0EC-8B6AE7EC1A41</gtr:id><gtr:outcomeId>58c84ec4b1f3a6.06558481</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Host targeted microRNA therapeutics for the treatment of viral infections</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Scottish Enterprise</gtr:fundingOrg><gtr:id>71627557-B2D9-4744-BFF8-AFDC084269AF</gtr:id><gtr:outcomeId>58c90a7b8df7d1.01132946</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>734000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>contract award</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Biomedical Advanced Research and Development Authority (BARDA)</gtr:fundingOrg><gtr:fundingRef>BARDA_BAA-11-100-SOL-00001</gtr:fundingRef><gtr:id>A4DEF7F9-DFF3-435A-AF42-1136044DDB82</gtr:id><gtr:outcomeId>58c849d8e359c0.62803340</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>94126</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Animal Health Research Club</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/M502972/1</gtr:fundingRef><gtr:id>1F5A28BD-011D-4372-A4B6-9B0FA5C02819</gtr:id><gtr:outcomeId>58b596e042ff18.32718100</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>367000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>CALL: INTEGRATING AND OPENING RESEARCH INFRASTRUCTURES OF EUROPEAN INTEREST</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:fundingRef>H2020-INFRAIA-2016-1 project number 731014</gtr:fundingRef><gtr:id>87176D02-D1EE-4B55-ABF7-A3FD2B4D180C</gtr:id><gtr:outcomeId>58c9abde184e71.27482896</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>BBSRC strategic investment at Roslin via this and other Institute Strategic Programmes has sustained expertise and facilities that have attracted substantial inward investment at Easter Bush. This has recently included &amp;pound;15M Gates Foundation funding to establish the Centre for Tropical Livestock Genetics &amp;amp; Health to implement genetic gain and treatments in support of farmers in low- and middle-income farmers, including to control endemic and zoonotic diseases. It has also driven dozens of productive collaborations with industry via contracts and leveraging schemes, leading to &amp;pound;10M private equity investment to form Roslin Technologies to commercialise our research and construction of a
new &amp;pound;32M Innovation Centre adjacent to the Institute to engage and grow businesses. Moreover, the expertise supported by this funding has attracted major investment in Agri-Tech Centres at Easter Bush funded by InnovateUK (Centre for Innovation Excellence in Livestock &amp;amp; Agri-EPI). These Centres will increase national capacity for infectious challenge in
farmed animals, gene editing and collection of novel phenotypes and be linked to stakeholders throughout the food supply chain.

Specific examples of impact are:

Our Porcine Epidemic Diarrhea Virus S1 diganostic ELISA was the first of its kind and Hipra, Spain (www.hipra.com) has taken the method and our construct on board and now have offer a PEDV ELISA kit for sale.</gtr:description><gtr:firstYearOfImpact>2016</gtr:firstYearOfImpact><gtr:id>D91B46A6-9C69-4368-9532-94E206B7A4DC</gtr:id><gtr:impactTypes/><gtr:outcomeId>56e0531fccdf36.53985926</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Education,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to newly identified avian genes which encode proteins which bind avian colony stimulating factor 1 receptor (CSF1R). Through binding to CSF1R, these proteins exhibit immunomodulatory properties which may be exploited to modulate the avian immune system as well as effects on cell growth, differentiation and/or proliferation, organ/tissue development and vaccine efficacy.</gtr:description><gtr:grantRef>BBS/E/D/20241866</gtr:grantRef><gtr:id>5FC8042F-8C35-455A-A182-3D2D6F4C57D5</gtr:id><gtr:impact>This has led to further patents (outside the remit of this grant).</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56e031044502a8.33420103</gtr:outcomeId><gtr:patentId>0910833.3</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Avian Genes (Colony stimulating factor 1)</gtr:title><gtr:yearProtectionGranted>2009</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to methods for enhancing the expression of proteins by
modifying the nucleotide composition of the encoding nucleic acid. In particular it relates to
methods for enhancing the expression of RNA expression vectors, by reducing the
frequency of CpG and/or UpA dinucleotides. The invention also relates to nucleic acids
modified in such a way, and to systems in which such nucleic acids are used.</gtr:description><gtr:grantRef>BBS/E/D/20241866</gtr:grantRef><gtr:id>6ED72C22-B567-402B-A8D3-B8BF9967828B</gtr:id><gtr:impact>None yet</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56e035f3b10779.67859532</gtr:outcomeId><gtr:patentId>GB1305361.6</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Enhanced expression</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Identification of a panel of peptides which inhibit replication of influenza A virus in vitro and in vivo</gtr:description><gtr:grantRef>BBS/E/D/20241866</gtr:grantRef><gtr:id>09AC1CD9-7F34-4526-BEE8-6F22B9945214</gtr:id><gtr:impact>None yet</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58b6ca7b56e703.28744653</gtr:outcomeId><gtr:patentId>GB2011/051436</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Peptides</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>An objective was development of vaccines based around pox virus and herpesvirus delivery systems. In collaboration with Dr Michael Jarvis, University of Plymouth, we developed murine cytomegalovirus recombinants expressing IAV CTL epitopes and tested their ability to protect against lethal IAV infection in mice. Unfortunately, we were not able to demonstrate protection. (PIs, Dutia, Digard).

We also explored the development of a novel antiviral peptide, FluPep which we showed had antiviral activity in vitro and in vivo could protect against a lethal influenza A virus (IAV) infection. Although we were able to obtain a small amount of funding from Apeptico and also approached larger companies (Roche), we were not able to obtain sufficient funds to develop this commercially. (PIs Dutia, Nash, Digard).

Our discovery of the PA-X pathogenicity-determining gene in IAV has led to the further findings that removing PA-X expression from the PR8 strain of the virus decreases pathogenicity in embryonated hens eggs. This is important because (a) 100s of millions of hens eggs are used annually to grow flu vaccine shots based on the PR8 virus an (b) we have found that this reduction in viral pathogenicity can increase the yield of vaccine from otherwise poor-yielding strains. (PI Digard).</gtr:description><gtr:exploitationPathways>We are actively trying to commercialise the PA-X based method for improving vaccine yield. Patent protection has been sought (Improved flu vaccine yield. P. Digard, The University Court of the University of Edinburgh. UK patent application no 1602535.5 (22/2/16).) and our business development team are in contact with potential industrial partners.</gtr:exploitationPathways><gtr:id>DD1996BB-0741-45D6-9BBC-334EFCC62A57</gtr:id><gtr:outcomeId>56e05309687a30.53389822</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A test to develop antibodies to PDCoV IgA and IgG antibodies for early detection of infection was developed.</gtr:description><gtr:id>D7A41D0C-8E3B-4756-9257-A96F6DAE0CD6</gtr:id><gtr:impact>The test is used for early detection of infection of a pig herd with PDCoV.</gtr:impact><gtr:outcomeId>58c7a89082bde7.33670725</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PDCoV-ELISA</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We improved a caesarean-derived, colostrum deprived pig model to ensure that animal welfare and survivability of pigs increases.</gtr:description><gtr:id>090DC621-E4B3-479B-9130-4E8FD5FD32AB</gtr:id><gtr:impact>Survivability of pigs increased from 50% to 90-100%</gtr:impact><gtr:outcomeId>58c7a7d6ca10a2.40533419</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CDCD pig model</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An ELISA for detection of IgG and IgA PEDV antibodies was developed.</gtr:description><gtr:id>74A4513D-8D6A-4441-9A5E-016816370CC8</gtr:id><gtr:impact>Test is used to determine if pig herds are free of PEDV</gtr:impact><gtr:outcomeId>58c7a843372ad8.96511326</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PEDV assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>One of the aims of the project is to design CRISPR guide sequences against each of the annotated genes for pig and chicken using the most advanced algorithms available. this has now been achieved and selected guide sequences are being test in pig and chicken cell lines to determine efficacy. Once the full libraries have been validated the guide sequences will be made publicly available through dedicated pig and chicken genome websites.</gtr:description><gtr:id>1CC61EB8-7620-4B6E-BF3E-3D52D66665C9</gtr:id><gtr:impact>Once publicly available, any researcher will be able to search for guide sequences to their gene of interest, allowing rapid generation of guide sequences to generate knockout libraries.</gtr:impact><gtr:outcomeId>58b54dc635def3.32304817</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>In silico generation of genome wide guide sequences for pig and chicken</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2F6570A7-80A6-4BE7-B0C0-72612276DE3C</gtr:id><gtr:title>A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4dad70ad74f30196ebfe4b49c0360864"><gtr:id>4dad70ad74f30196ebfe4b49c0360864</gtr:id><gtr:otherNames>Matzinger SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>58c6d310132bb2.58660202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>136780CF-01C1-48F7-A009-03B2B77A2675</gtr:id><gtr:title>Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c5d64eed95c3d26088351ba1dbab6a4"><gtr:id>0c5d64eed95c3d26088351ba1dbab6a4</gtr:id><gtr:otherNames>Muratore G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>56e04d89c0ffb6.50429826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B97A4DD8-F20B-4C83-BCB0-4B9DA036A49E</gtr:id><gtr:title>A gene expression atlas of the domestic pig.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec4b46deb7139726b4d65620417ac21d"><gtr:id>ec4b46deb7139726b4d65620417ac21d</gtr:id><gtr:otherNames>Freeman TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>5a72fe89266248.40967085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>353151A4-F6C8-4898-BD76-F4B484184AB5</gtr:id><gtr:title>Prevention of influenza by targeting host receptors using engineered proteins.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e39c0271d699747762754ec2b1a574d"><gtr:id>0e39c0271d699747762754ec2b1a574d</gtr:id><gtr:otherNames>Connaris H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56e050aee48767.41012804</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B999FC33-87D8-474E-99EA-C6DAAC1C025F</gtr:id><gtr:title>Redefining the &amp;quot;carrier&amp;quot; state for foot-and-mouth disease from the dynamics of virus persistence in endemically affected cattle populations.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e136ba6be09f1bbcb1180d7dc956282"><gtr:id>5e136ba6be09f1bbcb1180d7dc956282</gtr:id><gtr:otherNames>Bronsvoort BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c99a83759360.63907937</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28175625-2C8B-4964-BD00-CE01B974E89A</gtr:id><gtr:title>High altitude adaptation in Daghestani populations from the Caucasus.</gtr:title><gtr:parentPublicationTitle>Human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e20d67348aa917c1bc28c23479623899"><gtr:id>e20d67348aa917c1bc28c23479623899</gtr:id><gtr:otherNames>Pagani L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-6717</gtr:issn><gtr:outcomeId>5a72fe89aa6313.03136747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>13B1A9D3-4221-45DE-BF6D-1E33C0E10D5D</gtr:id><gtr:title>Professor Pete Kaiser 1964-2016.</gtr:title><gtr:parentPublicationTitle>Avian pathology : journal of the W.V.P.A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/183721c90fc07d20966ffda279b321e8"><gtr:id>183721c90fc07d20966ffda279b321e8</gtr:id><gtr:otherNames>Stevens M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0307-9457</gtr:issn><gtr:outcomeId>58bd7ae53bb2c4.41871997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECE5C125-19A7-453E-ADC3-C0DF834B6361</gtr:id><gtr:title>Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/312143ce98737e5c1ca071f56da2fe4e"><gtr:id>312143ce98737e5c1ca071f56da2fe4e</gtr:id><gtr:otherNames>Amorim MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56e04d88d770e6.21741137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92D7243A-306F-43C2-8608-66291604202F</gtr:id><gtr:title>An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd58c929d81d93485229acee9e3f8deb"><gtr:id>bd58c929d81d93485229acee9e3f8deb</gtr:id><gtr:otherNames>Fontanella E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58c6d11349e9c3.93961856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8EC5E4F-FE80-4695-917A-85ACBD73F3EC</gtr:id><gtr:title>Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c5d64eed95c3d26088351ba1dbab6a4"><gtr:id>0c5d64eed95c3d26088351ba1dbab6a4</gtr:id><gtr:otherNames>Muratore G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56e04d8cc0a684.34481951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF3CFE9A-FADC-4893-9818-1A59E3B9A03D</gtr:id><gtr:title>IFITM3 restricts the morbidity and mortality associated with influenza.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8080feaaa6a1c8bc11a2811ee3812b4f"><gtr:id>8080feaaa6a1c8bc11a2811ee3812b4f</gtr:id><gtr:otherNames>Everitt AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a72fe88e841f1.68701778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A705406C-9C4F-45C3-A77E-8688A187BC1E</gtr:id><gtr:title>The role of host genetics in susceptibility to influenza: a systematic review.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/658c566277d0d1cc6f4df2bec640e16c"><gtr:id>658c566277d0d1cc6f4df2bec640e16c</gtr:id><gtr:otherNames>Horby P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a72fe8a57dca1.43793296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A004282-E999-4B13-A6DB-907B133B9BE4</gtr:id><gtr:title>Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a89d9634dd2fa08a1aa4804dd8ebeadb"><gtr:id>a89d9634dd2fa08a1aa4804dd8ebeadb</gtr:id><gtr:otherNames>Burkard C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>58b5916951dc11.47058332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14680233-CDBC-4D16-957C-06CE643D8A56</gtr:id><gtr:title>Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c73d8dc8636376a69bd10e13b0bde588"><gtr:id>c73d8dc8636376a69bd10e13b0bde588</gtr:id><gtr:otherNames>Pi?eyro PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>56e04fbd8a3be0.77116484</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E8E7A36-82AD-4791-BE0E-792A41E1BA5A</gtr:id><gtr:title>Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c73d8dc8636376a69bd10e13b0bde588"><gtr:id>c73d8dc8636376a69bd10e13b0bde588</gtr:id><gtr:otherNames>Pi?eyro PE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>56e04fbd3bf609.94190592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2448BDD2-02F0-49E8-8CE1-09BE7809AED7</gtr:id><gtr:title>Evaluation of the efficacy of a commercial inactivated genogroup 2b-based porcine epidemic diarrhea virus (PEDV) vaccine and experimental live genogroup 1b exposure against 2b challenge.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaba948390a898d5255cdad54145c60b"><gtr:id>aaba948390a898d5255cdad54145c60b</gtr:id><gtr:otherNames>Opriessnig T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>5a8402be911443.80971579</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1595B83-8FF4-489E-986E-2EE2463456F3</gtr:id><gtr:title>Sustaining Interferon Induction by a High-Passage Atypical Porcine Reproductive and Respiratory Syndrome Virus Strain.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51bf4dfa986916ecad0537b64e1e1c57"><gtr:id>51bf4dfa986916ecad0537b64e1e1c57</gtr:id><gtr:otherNames>Ma Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c6d30f3c2ab1.38534482</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10A4ED9C-7D3C-416E-8EA6-A8038E1A5F7C</gtr:id><gtr:title>In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25fe729ac3cfa6c00ed80a3d003c92"><gtr:id>4a25fe729ac3cfa6c00ed80a3d003c92</gtr:id><gtr:otherNames>Subramaniam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>56e04fbe9c03f2.62248411</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D430BAA2-2B9C-43EA-A382-1436E5E69738</gtr:id><gtr:title>Detection of antibodies against porcine epidemic diarrhea virus in serum and colostrum by indirect ELISA.</gtr:title><gtr:parentPublicationTitle>Veterinary journal (London, England : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa72bea1b47c5b3dffdd987420836f27"><gtr:id>aa72bea1b47c5b3dffdd987420836f27</gtr:id><gtr:otherNames>Gerber PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1090-0233</gtr:issn><gtr:outcomeId>56e04fbf060076.15698352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD5E4F89-7EAE-4CDD-B8A9-0F08921B50A8</gtr:id><gtr:title>A live-attenuated and an inactivated chimeric porcine circovirus (PCV)1-2 vaccine are both effective at inducing a humoral immune response and reducing PCV2 viremia and intrauterine infection in female swine of breeding age.</gtr:title><gtr:parentPublicationTitle>Canadian journal of veterinary research = Revue canadienne de recherche veterinaire</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d0c4d67cb6d3c912c0da294aaf09ff3"><gtr:id>5d0c4d67cb6d3c912c0da294aaf09ff3</gtr:id><gtr:otherNames>Hemann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0830-9000</gtr:issn><gtr:outcomeId>58c6d31591c972.01472720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AC27FAD-526C-4B49-9575-3E381D8A4ECE</gtr:id><gtr:title>Role of microRNAs in herpesvirus latency and persistence.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d687093c51680cb3ef6962e14004d553"><gtr:id>d687093c51680cb3ef6962e14004d553</gtr:id><gtr:otherNames>Grey F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>58b552566d6d02.06394049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A7A64C8-6BB4-4CD9-B02C-B7934B4355D7</gtr:id><gtr:title>Development and validation of a 4-plex antibody assay for simultaneous detection of IgG antibodies against Torque teno sus virus 1 (TTSuV1), TTSuV2, and porcine reproductive and respiratory syndrome virus types 1 and 2.</gtr:title><gtr:parentPublicationTitle>Research in veterinary science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f9822220eca3a9dfec2f0e52d7950b2"><gtr:id>4f9822220eca3a9dfec2f0e52d7950b2</gtr:id><gtr:otherNames>Gim?nez-Lirola LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0034-5288</gtr:issn><gtr:outcomeId>56e04fbf74d885.93725178</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46A9B0DC-16C1-490B-A202-21F173349759</gtr:id><gtr:title>Conservation and divergence in Toll-like receptor 4-regulated gene expression in primary human versus mouse macrophages.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1cdd2b7d864d5d0390a254387307ae2"><gtr:id>b1cdd2b7d864d5d0390a254387307ae2</gtr:id><gtr:otherNames>Schroder K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a72fe897532d6.73476273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A77D67C3-054D-4396-BAD5-D14F4D623D6C</gtr:id><gtr:title>Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaba948390a898d5255cdad54145c60b"><gtr:id>aaba948390a898d5255cdad54145c60b</gtr:id><gtr:otherNames>Opriessnig T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58c6d314885578.00677186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E44E492-CE1E-47D5-A3B1-DA740F12EB33</gtr:id><gtr:title>The Vaccination of 35,000 Dogs in 20 Working Days Using Combined Static Point and Door-to-Door Methods in Blantyre, Malawi.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b48547ac2342a252edbae7ddfbaeb153"><gtr:id>b48547ac2342a252edbae7ddfbaeb153</gtr:id><gtr:otherNames>Gibson AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>58c99c552d4123.69391044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42E7D338-D346-4973-8156-DCF946634A9B</gtr:id><gtr:title>Gateways to the FANTOM5 promoter level mammalian expression atlas.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf199d738fd64a955cfeb3e7c9c2657b"><gtr:id>cf199d738fd64a955cfeb3e7c9c2657b</gtr:id><gtr:otherNames>Lizio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5a72fe886316d3.53680863</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA527CE5-F1A5-4DD4-918E-76917B14268D</gtr:id><gtr:title>Porcine epidemic diarrhea virus RNA present in commercial spray-dried porcine plasma is not infectious to na&amp;iuml;ve pigs.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaba948390a898d5255cdad54145c60b"><gtr:id>aaba948390a898d5255cdad54145c60b</gtr:id><gtr:otherNames>Opriessnig T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e04fc0a0e5e1.82428214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC0EB6C3-13CD-42C8-9068-30954729E925</gtr:id><gtr:title>Cellular v-ATPase is required for virion assembly compartment formation in human cytomegalovirus infection.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/807be3bc1597cca2b8ceb37241c16a2c"><gtr:id>807be3bc1597cca2b8ceb37241c16a2c</gtr:id><gtr:otherNames>Pavelin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>5a2fd806bfc3a8.56856678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A933348-B69E-43EC-A103-A07C22FED77C</gtr:id><gtr:title>Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845a6641ac61a180ca5f79ff6df4e118"><gtr:id>845a6641ac61a180ca5f79ff6df4e118</gtr:id><gtr:otherNames>Tian D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5a8402be022e12.79253190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A45F562-CB69-4976-82A3-9DD70E0E2346</gtr:id><gtr:title>Chimeric porcine reproductive and respiratory syndrome virus containing shuffled multiple envelope genes confers cross-protection in pigs.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845a6641ac61a180ca5f79ff6df4e118"><gtr:id>845a6641ac61a180ca5f79ff6df4e118</gtr:id><gtr:otherNames>Tian D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>56e04fbdb0abc7.20679761</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60455054-0C76-4784-A3D3-1F23604F9A66</gtr:id><gtr:title>The middle half genome of interferon-inducing porcine reproductive and respiratory syndrome virus strain A2MC2 is essential for interferon induction.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51bf4dfa986916ecad0537b64e1e1c57"><gtr:id>51bf4dfa986916ecad0537b64e1e1c57</gtr:id><gtr:otherNames>Ma Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>5a8402bf04f6c2.17996552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50D8E45B-0EBF-42F5-BB44-DCA439663B2C</gtr:id><gtr:title>A novel family of peptides with potent activity against influenza A viruses.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9db13822d720ed6f93332e10af08955"><gtr:id>c9db13822d720ed6f93332e10af08955</gtr:id><gtr:otherNames>Nicol MQ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56e050af791260.06555868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8E8A5D6-3110-4DA1-8A8D-0D589DC5017D</gtr:id><gtr:title>Detection of immunoglobulin (Ig) A antibodies against porcine epidemic diarrhea virus (PEDV) in fecal and serum samples.</gtr:title><gtr:parentPublicationTitle>MethodsX</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa72bea1b47c5b3dffdd987420836f27"><gtr:id>aa72bea1b47c5b3dffdd987420836f27</gtr:id><gtr:otherNames>Gerber PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2215-0161</gtr:issn><gtr:outcomeId>56e04fbe7749c5.85258229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9C737F0-B7C2-494B-9DC7-56CF2F38E05D</gtr:id><gtr:title>A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaba948390a898d5255cdad54145c60b"><gtr:id>aaba948390a898d5255cdad54145c60b</gtr:id><gtr:otherNames>Opriessnig T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58c6d315b02eb2.56884871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB11508B-BCF2-4F74-B981-E1EA7EEC587D</gtr:id><gtr:title>A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88fec5e04b10d543474d3ab320493439"><gtr:id>88fec5e04b10d543474d3ab320493439</gtr:id><gtr:otherNames>Beard PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e04cb5716777.58996746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DE3E97E-74EB-4CE8-8E08-8125F9E72BC8</gtr:id><gtr:title>Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78a171c9720b4cd0b5693403afa51065"><gtr:id>78a171c9720b4cd0b5693403afa51065</gtr:id><gtr:otherNames>Munday DC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>56e04d86338925.52356022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE6815E8-EDC8-4539-ACF9-7BE279C186BA</gtr:id><gtr:title>Efficient priming of CD4 T cells by Langerin-expressing dendritic cells targeted with porcine epidemic diarrhea virus spike protein domains in pigs.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a25fe729ac3cfa6c00ed80a3d003c92"><gtr:id>4a25fe729ac3cfa6c00ed80a3d003c92</gtr:id><gtr:otherNames>Subramaniam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>58c6d30ee624d0.17475682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E978E93A-B137-49AB-A0BC-B241278F4E49</gtr:id><gtr:title>The spray-drying process is sufficient to inactivate infectious porcine epidemic diarrhea virus in plasma.</gtr:title><gtr:parentPublicationTitle>Veterinary microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa72bea1b47c5b3dffdd987420836f27"><gtr:id>aa72bea1b47c5b3dffdd987420836f27</gtr:id><gtr:otherNames>Gerber PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0378-1135</gtr:issn><gtr:outcomeId>56e04fbed51426.36830801</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>002D9516-5CE9-4979-9805-FF950A3FD717</gtr:id><gtr:title>Vaccinate-assess-move method of mass canine rabies vaccination utilising mobile technology data collection in Ranchi, India.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b48547ac2342a252edbae7ddfbaeb153"><gtr:id>b48547ac2342a252edbae7ddfbaeb153</gtr:id><gtr:otherNames>Gibson AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>58c99c54f0b592.22481527</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79AD37D9-2F26-45DB-932B-5D2AF923CDDB</gtr:id><gtr:title>Enhancing neutralizing antibody production by an interferon-inducing porcine reproductive and respiratory syndrome virus strain.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17f6633e9d8a0b4804343fbc2df4165c"><gtr:id>17f6633e9d8a0b4804343fbc2df4165c</gtr:id><gtr:otherNames>Wang R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58c6d31656faa4.94662487</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7819C34-A69B-43F3-9B4F-F3C3A2690BAC</gtr:id><gtr:title>Mixed treatment comparison meta-analysis of porcine circovirus type 2 (PCV2) vaccines used in piglets.</gtr:title><gtr:parentPublicationTitle>Preventive veterinary medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4302fdf8aaae527b7187ee8443fef404"><gtr:id>4302fdf8aaae527b7187ee8443fef404</gtr:id><gtr:otherNames>da Silva N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0167-5877</gtr:issn><gtr:outcomeId>58c6d312a91b61.33230978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0115B646-BDD2-4060-BB13-D82F617F2499</gtr:id><gtr:title>Elevation of CpG frequencies in influenza A genome attenuates pathogenicity but enhances host response to infection.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41b4d9c4bbad5a4fdfcb139a20ab3dbb"><gtr:id>41b4d9c4bbad5a4fdfcb139a20ab3dbb</gtr:id><gtr:otherNames>Gaunt E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56e04cb47cf354.42327367</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F461292B-96AD-4399-B016-07DCA918E55D</gtr:id><gtr:title>Comparison of the efficacy of a commercial inactivated influenza A/H1N1/pdm09 virus (pH1N1) vaccine and two experimental M2e-based vaccines against pH1N1 challenge in the growing pig model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaba948390a898d5255cdad54145c60b"><gtr:id>aaba948390a898d5255cdad54145c60b</gtr:id><gtr:otherNames>Opriessnig T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a8402bdccb0a0.75383494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9450C42C-8640-43DD-881A-A4B335B57E4F</gtr:id><gtr:title>Antiviral combinations for severe influenza.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3001ef648587e32ff894d3c73f9321ca"><gtr:id>3001ef648587e32ff894d3c73f9321ca</gtr:id><gtr:otherNames>Dunning J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5a72fe88af0670.82563048</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16BF80B7-7F44-40AF-A4A6-F9E5F76AC9BB</gtr:id><gtr:title>Analysis of bovine viral diarrhoea virus: Biobank and sequence database to support eradication in Scotland.</gtr:title><gtr:parentPublicationTitle>The Veterinary record</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72b1d69569f554a8b50f752c2624fa82"><gtr:id>72b1d69569f554a8b50f752c2624fa82</gtr:id><gtr:otherNames>Russell GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0042-4900</gtr:issn><gtr:outcomeId>5a85cb43594cf1.56602645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC89C06C-327A-48F8-B663-23FEF7380FEA</gtr:id><gtr:title>Quantifying predictors for the spatial diffusion of avian influenza virus in China.</gtr:title><gtr:parentPublicationTitle>BMC evolutionary biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a52ae52cf115d5f18b9025c28dd0b6b"><gtr:id>5a52ae52cf115d5f18b9025c28dd0b6b</gtr:id><gtr:otherNames>Lu L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2148</gtr:issn><gtr:outcomeId>58a48ffdacca64.37363701</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B200BF84-1450-4368-8D26-D79C9531C4E9</gtr:id><gtr:title>A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc4eca0e88cd95e2abf344f636709b52"><gtr:id>fc4eca0e88cd95e2abf344f636709b52</gtr:id><gtr:otherNames>Evenson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58c6d30f871d66.08381289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>505787E5-1EAE-46CD-B6A4-913517E88868</gtr:id><gtr:title>Comparison of commercial enzyme-linked immunosorbent assays and fluorescent microbead immunoassays for detection of antibodies against porcine reproductive and respiratory syndrome virus in boars.</gtr:title><gtr:parentPublicationTitle>Journal of virological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa72bea1b47c5b3dffdd987420836f27"><gtr:id>aa72bea1b47c5b3dffdd987420836f27</gtr:id><gtr:otherNames>Gerber PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0166-0934</gtr:issn><gtr:outcomeId>56e04fc0050738.90542481</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52330802-DFD5-4C01-AD6A-FD5662BB0F04</gtr:id><gtr:title>An Influenza Virus M2 Protein Specific Chimeric Antigen Receptor Modulates Influenza A/WSN/33 H1N1 Infection In Vivo.</gtr:title><gtr:parentPublicationTitle>The open virology journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/330acfed85d4f38728aec9a88f429671"><gtr:id>330acfed85d4f38728aec9a88f429671</gtr:id><gtr:otherNames>Talbot SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1874-3579</gtr:issn><gtr:outcomeId>56e050af21ba40.84105222</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B8386D2-2214-4F81-BDBB-256685C9569B</gtr:id><gtr:title>Increased frequency of porcine epidemic diarrhea virus shedding and lesions in suckling pigs compared to nursery pigs and protective immunity in nursery pigs after homologous re-challenge.</gtr:title><gtr:parentPublicationTitle>Veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa72bea1b47c5b3dffdd987420836f27"><gtr:id>aa72bea1b47c5b3dffdd987420836f27</gtr:id><gtr:otherNames>Gerber PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0928-4249</gtr:issn><gtr:outcomeId>58c6d30ebf6bf5.58634668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63C68144-6BDA-486A-B5D2-41757A2F6675</gtr:id><gtr:title>The host ubiquitin-dependent segregase VCP/p97 is required for the onset of human cytomegalovirus replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce9a0c1ed838364326b1a9f7b0fe5c16"><gtr:id>ce9a0c1ed838364326b1a9f7b0fe5c16</gtr:id><gtr:otherNames>Lin YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5a2fd3322b2480.07195988</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDEA978E-9C05-48C2-8725-5A012E54DA30</gtr:id><gtr:title>RNA interference targets arbovirus replication in Culicoides cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b89354079a660811744cb1a251293992"><gtr:id>b89354079a660811744cb1a251293992</gtr:id><gtr:otherNames>Schnettler E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5448cae1d89c10.90314828</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F94D465-1360-407A-8A90-14B7311B9D19</gtr:id><gtr:title>Computer-aided codon-pairs deoptimization of the major envelope GP5 gene attenuates porcine reproductive and respiratory syndrome virus.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40732a5e3873b1dd6658135bac43841b"><gtr:id>40732a5e3873b1dd6658135bac43841b</gtr:id><gtr:otherNames>Ni YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>56e04fc031ef15.04958152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA30DC54-A966-4F4A-99CB-600C4D81D582</gtr:id><gtr:title>Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa4e3e4f0ff2b20c2e0b0493376fecd8"><gtr:id>aa4e3e4f0ff2b20c2e0b0493376fecd8</gtr:id><gtr:otherNames>Baillie JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>5a72fe8797e2c7.15776756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2463D470-0860-423F-8D9D-523664EB8ABF</gtr:id><gtr:title>Evaluation of serological cross-reactivity and cross-neutralization between the United States porcine epidemic diarrhea virus prototype and S-INDEL-variant strains.</gtr:title><gtr:parentPublicationTitle>BMC veterinary research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87baae63149e8384883159bbff301f14"><gtr:id>87baae63149e8384883159bbff301f14</gtr:id><gtr:otherNames>Chen Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1746-6148</gtr:issn><gtr:outcomeId>58c6d310acd366.27744297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAD52913-62C5-425A-9C1E-834586352DF7</gtr:id><gtr:title>Assessing the potential for Bluetongue virus 8 to spread and vaccination strategies in Scotland.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95ad10a14c6274dd8463da4c1181c5e1"><gtr:id>95ad10a14c6274dd8463da4c1181c5e1</gtr:id><gtr:otherNames>Bessell PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c99a82de9ab5.95023082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DE041E3-DF37-4C8A-9297-70799FABE538</gtr:id><gtr:title>Enhancing heterologous protection in pigs vaccinated with chimeric porcine reproductive and respiratory syndrome virus containing the full-length sequences of shuffled structural genes of multiple heterologous strains.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/845a6641ac61a180ca5f79ff6df4e118"><gtr:id>845a6641ac61a180ca5f79ff6df4e118</gtr:id><gtr:otherNames>Tian D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5a8402beafad55.62450006</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC6E11A-2748-4060-9937-4BFCC590B37B</gtr:id><gtr:title>Retinal vessel tortuosity in response to hypobaric hypoxia.</gtr:title><gtr:parentPublicationTitle>High altitude medicine &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a0c8f66431b9bf6c5d6fd3450483d96"><gtr:id>0a0c8f66431b9bf6c5d6fd3450483d96</gtr:id><gtr:otherNames>MacCormick IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1527-0297</gtr:issn><gtr:outcomeId>5a72fe8a22df14.72581601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED29A0BF-FE6A-4CCB-8F47-3735F5249EDE</gtr:id><gtr:title>Treatable traits and therapeutic targets: Goals for systems biology in infectious disease</gtr:title><gtr:parentPublicationTitle>Current Opinion in Systems Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98b39eadab80fc5f2244370bc628b60d"><gtr:id>98b39eadab80fc5f2244370bc628b60d</gtr:id><gtr:otherNames>Russell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a72fe872a8321.74876056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3D2B5C7-7D4A-43ED-9FA1-8F4FF85E3C9E</gtr:id><gtr:title>Identification of novel genes selectively expressed in the follicle-associated epithelium from the meta-analysis of transcriptomics data from multiple mouse cell and tissue populations.</gtr:title><gtr:parentPublicationTitle>DNA research : an international journal for rapid publication of reports on genes and genomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33342a95a5440ee213f0804af9129157"><gtr:id>33342a95a5440ee213f0804af9129157</gtr:id><gtr:otherNames>Kobayashi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1340-2838</gtr:issn><gtr:outcomeId>5a72fe89e34db9.90966370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F3C211F-63A4-4DE6-A4E3-D84BFBAD2407</gtr:id><gtr:title>A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to na&amp;iuml;ve pigs under experimental conditions.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aaba948390a898d5255cdad54145c60b"><gtr:id>aaba948390a898d5255cdad54145c60b</gtr:id><gtr:otherNames>Opriessnig T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>58c6d112d2e395.82563757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1BC8388-0490-46F4-84F8-566E22841A5B</gtr:id><gtr:title>Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96799fca56db451b3077aa7e1b524568"><gtr:id>96799fca56db451b3077aa7e1b524568</gtr:id><gtr:otherNames>Hook LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>58b5540c887034.05306489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3E4AB9E-7A7A-40D1-994C-ECDD4DDF1361</gtr:id><gtr:title>Comparison of real-time reverse transcriptase PCR assays for detection of swine hepatitis E virus in fecal samples.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa72bea1b47c5b3dffdd987420836f27"><gtr:id>aa72bea1b47c5b3dffdd987420836f27</gtr:id><gtr:otherNames>Gerber PF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>56e04fbfa27534.28426343</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD3214E2-5D7F-4ED8-B556-95BC7D72DE39</gtr:id><gtr:title>Systematic microRNA analysis identifies ATP6V0C as an essential host factor for human cytomegalovirus replication.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/807be3bc1597cca2b8ceb37241c16a2c"><gtr:id>807be3bc1597cca2b8ceb37241c16a2c</gtr:id><gtr:otherNames>Pavelin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>58b554300cb9c3.36677496</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/D/20241866</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>